Soliris 300 MG/30 ML vial 30ML
Ended Awarded
- Contract number
- SPE2DR26FMDU2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,008
Award facts
- Contract value 100% obligated
- $41,008.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $41,008.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Soliris 300 mg/30 mL vials. The delivery order, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the federal military medical supply chain, with substantial contracting activity through the Defense Logistics Agency's Medical Supply Chain division. The company's portfolio encompasses an extensive range of pharmaceuticals including specialty biologics, oncology treatments, immunosuppressants, vaccines, and medical consumables. The underlying indefinite delivery contract, designated SPE2DR, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors supporting the Department of Defense's global pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2DR26FMDU2?
SPE2DR26FMDU2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FMDU2 worth?
The government has obligated $41,008 on SPE2DR26FMDU2.
Is contract SPE2DR26FMDU2 an order under another contract?
Yes. SPE2DR26FMDU2 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDU2 competed?
The extent of competition for SPE2DR26FMDU2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award